Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Eurofins Biopharma Product Testing Sweden AB
AB
Active
Org 5562252196
Rapsgatan 21, 754 50
Uppsala
Technical testing and analysis
· NACE 7120
Est. 1983
38 employees
Watchlist
Share
Sweden
/
Companies
/
Technical testing and analysis
/
Eurofins Biopharma Product Testing Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
25M
51M
76M
101M
61M
2020
56M
2021
62M
2022
68M
2023
88M
2024
EBITDA
SEK millions
0M
-1M
-2M
-3M
-3M
-3M
2020
-17M
2021
-14M
2022
-13M
2023
-4M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
60 767
56 116
61 765
67 508
87 739
Staff expenses
—
—
—
—
—
EBITDA
−3 159
−16 893
−14 342
−12 940
−3 562
Depreciation & amort.
−4 505
−5 205
−5 258
−5 350
−5 148
EBIT
−7 664
−22 098
−19 600
−18 290
−8 710
Net financials
−931
−1 070
−1 422
−2 084
−1 208
Profit before tax
1 324
−1 818
−21 022
−20 374
−9 918
Tax
−324
−3
4 130
38
−4 209
Net profit
1 000
−1 821
−16 892
−20 336
−14 127
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
48 642
61 324
46 159
36 643
26 500
Equity
7 881
18 560
1 668
−18 668
−6 985
Long-term debt
21 702
22 702
22 702
24 302
6 991
Short-term debt
13 576
13 937
13 888
21 816
16 453
Total debt
35 278
36 639
36 590
46 118
23 444
Financial ratios
5-year trend
EBITDA margin
-4.1%
This company
15.8%
Market median
-126% vs market
2020
2024
Equity ratio
-26.4%
This company
38.2%
Market median
-169% vs market
2020
2024
Return on equity
-1412700000.0%
This company
18.4%
Market median
-7677717491% vs market
2020
2024
Net profit margin
-16.1%
This company
8.1%
Market median
-299% vs market
2020
2024
Asset turnover
3.31×
This company
1.12×
Market median
+196% vs market
2020
2024
Debt / equity
4.79×
This company
0.62×
Market median
-673% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Eurofins Biopharma Product Testing Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
